ERBB2 and triple-negative breast carcinoma: The dataset included single-cell sequencing results from 26 cases of primary breast cancer tissues without chemotherapy, comprising 11 ER-positive, 5 HER2-positive, and 10 triple-negative breast cancer (TNBC) cases, along with cellular annotation information.